Increased risk of MAFLD and liver fibrosis in inflammatory bowel disease independent of classic metabolic risk factors. Rodriguez-Duque JC, Calleja JL, Iruzubieta P, Hernandez-Conde M, et al. Clin Gastroenterol Hepatol 2022 Feb 3. pii: S1542-3565(22)00093.

Read + Share

Amedeo Smart

Independent Medical Education

Rodriguez-Duque JC, Calleja JL, Iruzubieta P, Hernandez-Conde M, et al. Increased risk of MAFLD and liver fibrosis in inflammatory bowel disease independent of classic metabolic risk factors. Clin Gastroenterol Hepatol 2022 Feb 3. pii: S1542-3565(22)00093.
PMID: 35124272